fosamax lawyers
On October 13, 2010, the U.S. Food and Drug Administration (FDA) issued a femur fracture warning informing patients and wellness care providers about the feasible threat of atypical thigh bone (femur) fractures in patients who take bisphosphonates, such as Fosamax. Bisphosphonates are a class of drugs employed to prevent and treat osteoporosis. Atypical femur fractures, a rare but serious sort of thigh bone fracture, have been predominantly reported in patients taking drugs such as Fosamax for longer than five years.
A labeling alter and Medication Guide for Fosamax, Fosamax Plus D, and their generic merchandise will reflect this most current femur fracture warning by the FDA.
Scientific studies Support Femur Fracture Warning
With regard to this femur fracture warning, the FDA stated that it is &ldquocontinuing to evaluate information about the safety and effectiveness of bisphosphonates when employed extended-term for osteoporosis therapy.&rdquo &ldquoIn the interim, it&rsquos critical for patients and well being care specialists to have all the safety information obtainable when determining the very best course of remedy for osteoporosis.&rdquo
Nowadays&rsquos femur fracture warning follows a March ten, 2010 Drug Safety Communication announcing the FDA&rsquos ongoing safety assessment of bisphosphonate use and the occurrence of atypical femur fractures. The FDA has given that reviewed all available data on bisphosphonate use, including information summarized in the American Society for Bone Mineral Study Task Force report. The report proposed extra product labeling, better identification and tracking of patients experiencing these breaks, and a lot more study to figure out whether or not and how these drugs cause the significant but uncommon fractures.
Based on the FDA&rsquos review, the Warnings and Precautions section of all bisphosphonate goods for osteoporosis, which includes Fosamax, will be revised to contain the femur fracture warning, and the FDA will demand the inclusion of the very same femur fracture warning into a Medication Guide to greater inform patients of the achievable increased fracture threat. People who have suffered a femur fracture after taking Fosamax may want to file a fosamax lawsuit.
Given this latest femur fracture warning, the FDA recommends that well being care specialists be aware of the achievable threat in patients taking bisphosphonates and think about periodic reevaluation of the require for continued bisphosphonate therapy for patients who have been on bisphosphonates for longer than five years.
Patients taking bisphosphonates must report any new thigh or groin pain to their wellness care provider and be evaluated for a doable femur fracture. If you or someone you know have suffered a femur fracture after taking Fosamax contact a fosamax lawyer for help.